Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report)'s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $18.13 and last traded at $17.90, with a volume of 56018 shares trading hands. The stock had previously closed at $17.63.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on CCAP shares. Wells Fargo & Company upped their price target on Crescent Capital BDC from $16.00 to $16.50 and gave the stock an "equal weight" rating in a research report on Monday, January 29th. Oppenheimer upped their target price on Crescent Capital BDC from $18.00 to $19.00 and gave the company an "outperform" rating in a research report on Friday, February 23rd.
Read Our Latest Stock Report on Crescent Capital BDC
Crescent Capital BDC Stock Up 1.8 %
The company has a market capitalization of $664.86 million, a price-to-earnings ratio of 7.83 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.98 and a current ratio of 0.98. The business's 50 day moving average is $17.18 and its 200 day moving average is $16.84.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 21st. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.57 by $0.04. Crescent Capital BDC had a net margin of 45.54% and a return on equity of 11.32%. The business had revenue of $50.00 million during the quarter, compared to the consensus estimate of $47.99 million. Sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 2.26 earnings per share for the current year.
Crescent Capital BDC Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Friday, March 29th were paid a dividend of $0.41 per share. The ex-dividend date was Wednesday, March 27th. This represents a $1.64 annualized dividend and a yield of 9.14%. Crescent Capital BDC's payout ratio is presently 71.62%.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the company. International Assets Investment Management LLC acquired a new position in shares of Crescent Capital BDC in the 4th quarter valued at about $1,254,000. Confluence Investment Management LLC purchased a new stake in Crescent Capital BDC in the 1st quarter worth approximately $1,200,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Crescent Capital BDC in the 4th quarter worth approximately $843,000. Muzinich & Co. Inc. acquired a new position in shares of Crescent Capital BDC in the 4th quarter valued at $843,000. Finally, Mmbg Investment Advisors CO. purchased a new stake in Crescent Capital BDC during the fourth quarter worth $612,000. 49.46% of the stock is currently owned by hedge funds and other institutional investors.
Crescent Capital BDC Company Profile
(
Get Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
